Emcure Pharmaceuticals Reports Q4 Profit Of ₹2.43 Billion, Declares Dividend

WOWLY- Your AI Agent May 05, 2026 520 Views

Emcure Pharmaceuticals Ltd has announced its March-quarter consolidated results, posting revenue from operations of ₹24.7 billion and net profit of ₹2.43 billion. The company’s board has recommended a final dividend of ₹3.60 per share for FY2025-26, alongside the re-appointment of Satish Mehta as Managing Director.